IL249640A0 - תכשירים לטיפול בדימום מהאף - Google Patents

תכשירים לטיפול בדימום מהאף

Info

Publication number
IL249640A0
IL249640A0 IL249640A IL24964016A IL249640A0 IL 249640 A0 IL249640 A0 IL 249640A0 IL 249640 A IL249640 A IL 249640A IL 24964016 A IL24964016 A IL 24964016A IL 249640 A0 IL249640 A0 IL 249640A0
Authority
IL
Israel
Prior art keywords
epistaxis
compositions
treatment
Prior art date
Application number
IL249640A
Other languages
English (en)
Original Assignee
Eran Eilat
Evgenia Lozinsky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eran Eilat, Evgenia Lozinsky filed Critical Eran Eilat
Publication of IL249640A0 publication Critical patent/IL249640A0/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL249640A 2015-05-01 2016-12-19 תכשירים לטיפול בדימום מהאף IL249640A0 (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/001451 WO2016178053A1 (en) 2015-05-01 2015-05-01 Compositions for the treatment of epistaxis

Publications (1)

Publication Number Publication Date
IL249640A0 true IL249640A0 (he) 2017-02-28

Family

ID=57218149

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249640A IL249640A0 (he) 2015-05-01 2016-12-19 תכשירים לטיפול בדימום מהאף

Country Status (5)

Country Link
EP (1) EP3288636A4 (he)
CN (1) CN107073293A (he)
CA (1) CA2952818A1 (he)
IL (1) IL249640A0 (he)
WO (1) WO2016178053A1 (he)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018248422B2 (en) * 2017-04-04 2024-02-15 Anti-Plasmin Technologies, Llc Methods to enhance a non-surgical medical treatment
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CN114206349A (zh) 2019-04-17 2022-03-18 指南针探路者有限公司 治疗神经认知障碍、慢性疼痛及减轻炎症的方法
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
CN115667217A (zh) 2020-05-19 2023-01-31 赛本爱尔兰有限公司 氘化的色胺衍生物和使用方法
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
JP4959557B2 (ja) * 2004-07-09 2012-06-27 フェロサン メディカル デバイシーズ エイ／エス ヒアルロン酸含有止血合成剤
WO2011053801A2 (en) * 2009-10-30 2011-05-05 Intratus, Inc. Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
US20150231300A1 (en) * 2012-10-28 2015-08-20 Peritech Pharma Ltd. Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
AU2014229497A1 (en) * 2013-03-10 2015-09-24 Peritech Pharma Ltd. Topical compositions and methods of treatment of topical disorders

Also Published As

Publication number Publication date
EP3288636A1 (en) 2018-03-07
CA2952818A1 (en) 2016-11-10
EP3288636A4 (en) 2019-01-16
WO2016178053A1 (en) 2016-11-10
CN107073293A (zh) 2017-08-18

Similar Documents

Publication Publication Date Title
SG11201705093UA (en) Composition for treating il-6-related diseases
GB201501598D0 (en) Compositions
GB201514328D0 (en) Compositions
PT3261726T (pt) Composição para o tratamento do acne
GB201601572D0 (en) NO containing compositions
HK1257500A1 (zh) 包含尿石素化合物的組合物
IL249640A0 (he) תכשירים לטיפול בדימום מהאף
HK1255221A1 (zh) 使用卡多曲組合物進行治療的方法
GB201515391D0 (en) Compositions
HK1250627A1 (zh) 用於治療hcv的固體藥物組合物
HK1248130A1 (zh) 用於治療疼痛的組合物
HK1255203A1 (zh) 用於治療hcv的固體藥物組合物
EP3362085C0 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES WITH MUCIN
GB201517892D0 (en) Compositions
IL255167A0 (he) תרכובות לטיפול בסרטן
IL257492B (he) תכשירים המכילים fgf–18
SI3303486T1 (sl) Sestavek za površinsko obdelavo
GB201522541D0 (en) Compositions
IL267059A (he) תכשיר לטיפול בדלקת פרקים העצם
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
PT3524255T (pt) Composição para o tratamento do acne
GB201521083D0 (en) Compositions for treatment and methods thereof
GB201522892D0 (en) Compositions
GB201517841D0 (en) NO containing compositions
GB201507667D0 (en) Composition & process